Clinical Trial Update: A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This entry describes an ongoing Phase 1 clinical trial evaluating AND019 in women with ER-positive, HER2-negative advanced or metastatic breast cancer, which is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AND019

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Advanced or Metastatic Breast Cancer | Phase 1 | Status: RECRUITING